Decreased activation of this signaling has been associated with improved cardiomyocyte performance and an attenuation of age-related structural changes in cardiomyocytes (112, 113); however, studies in humans have shown a correlation between low IGF-I levels and an increased risk for heart failure in elderly patients (114). The gene discussed is IGF1; the disease is heart failure.